{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Severe hypertriglyceridaemia",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_fibrates",
          "name": "Fibrates"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_statins",
          "name": "Statins"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_omega_3_fatty_acids",
          "name": "Omega-3 fatty acids"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_niacin",
          "name": "Niacin"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_lipid_lowering_medications",
          "name": "Lipid-lowering medications"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_ezetimibe",
          "name": "Ezetimibe"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_pcsk9_inhibitors",
          "name": "PCSK9 inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_angiopoietin_like_3_inhibitors",
          "name": "Angiopoietin-like 3 inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_gemfibrozil",
          "name": "Gemfibrozil"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_fenofibrate",
          "name": "Fenofibrate"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_fish_oil_supplements",
          "name": "Fish oil supplements"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_red_yeast_rice",
          "name": "Red yeast rice"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [
      {
        "hypothesis_id": "H1",
        "score": 0.48,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.4,
          "safety_risk": 0.25,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.15
        },
        "graph_signals": {
          "support_weight": 0.85,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "不良反应的抵消效应",
              "pro": [
                "n_fibrates"
              ],
              "con": [
                "n_rp"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "已知对高甘油三酯血症的临床适应症"
          ],
          "safety_risk": [
            "不良反应可能抵消治疗收益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H2",
        "score": 0.48,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.4,
          "safety_risk": 0.25,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.15
        },
        "graph_signals": {
          "support_weight": 0.8,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "不良反应的抵消效应",
              "pro": [
                "n_statins"
              ],
              "con": [
                "n_rp"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "具有降低甘油三酯的有效性"
          ],
          "safety_risk": [
            "不良反应可能抵消治疗收益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H3",
        "score": 0.42,
        "components": {
          "mechanism_fit": 0.65,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.4,
          "safety_risk": 0.25,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.15
        },
        "graph_signals": {
          "support_weight": 0.75,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "不良反应的抵消效应",
              "pro": [
                "n_omega_3_fatty_acids"
              ],
              "con": [
                "n_rp"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "临床研究表明降低甘油三酯"
          ],
          "safety_risk": [
            "不良反应可能抵消治疗收益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H4",
        "score": 0.42,
        "components": {
          "mechanism_fit": 0.65,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.4,
          "safety_risk": 0.25,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.15
        },
        "graph_signals": {
          "support_weight": 0.7,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "不良反应的抵消效应",
              "pro": [
                "n_niacin"
              ],
              "con": [
                "n_rp"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "对高甘油三酯血症有效的常识支持"
          ],
          "safety_risk": [
            "不良反应可能抵消治疗收益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H5",
        "score": 0.45,
        "components": {
          "mechanism_fit": 0.6,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.4,
          "safety_risk": 0.25,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.15
        },
        "graph_signals": {
          "support_weight": 0.65,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "不良反应的抵消效应",
              "pro": [
                "n_lipid_lowering_medications"
              ],
              "con": [
                "n_rp"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "包含多种降脂药物的合成支持"
          ],
          "safety_risk": [
            "不良反应可能抵消治疗收益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H6",
        "score": 0.4,
        "components": {
          "mechanism_fit": 0.6,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.4,
          "safety_risk": 0.25,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.15
        },
        "graph_signals": {
          "support_weight": 0.6,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "不良反应的抵消效应",
              "pro": [
                "n_ezetimibe"
              ],
              "con": [
                "n_rp"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "在治疗高脂血症中的作用"
          ],
          "safety_risk": [
            "不良反应可能抵消治疗收益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H7",
        "score": 0.38,
        "components": {
          "mechanism_fit": 0.55,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.4,
          "safety_risk": 0.25,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.15
        },
        "graph_signals": {
          "support_weight": 0.55,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "不良反应的抵消效应",
              "pro": [
                "n_pcsk9_inhibitors"
              ],
              "con": [
                "n_rp"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "可能对高甘油三酯有辅助效果"
          ],
          "safety_risk": [
            "不良反应可能抵消治疗收益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H8",
        "score": 0.36,
        "components": {
          "mechanism_fit": 0.55,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.4,
          "safety_risk": 0.25,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.15
        },
        "graph_signals": {
          "support_weight": 0.5,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "不良反应的抵消效应",
              "pro": [
                "n_angiopoietin_like_3_inhibitors"
              ],
              "con": [
                "n_rp"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "理论上对甘油三酯影响"
          ],
          "safety_risk": [
            "不良反应可能抵消治疗收益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H9",
        "score": 0.48,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.4,
          "safety_risk": 0.25,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.15
        },
        "graph_signals": {
          "support_weight": 0.65,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "不良反应的抵消效应",
              "pro": [
                "n_gemfibrozil"
              ],
              "con": [
                "n_rp"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "用于高甘油三酯的已知药物"
          ],
          "safety_risk": [
            "不良反应可能抵消治疗收益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H10",
        "score": 0.45,
        "components": {
          "mechanism_fit": 0.6,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.4,
          "safety_risk": 0.25,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.15
        },
        "graph_signals": {
          "support_weight": 0.55,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "不良反应的抵消效应",
              "pro": [
                "n_fenofibrate"
              ],
              "con": [
                "n_rp"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "有效降低甘油三酯的药物"
          ],
          "safety_risk": [
            "不良反应可能抵消治疗收益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H11",
        "score": 0.35,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.4,
          "safety_risk": 0.25,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.15
        },
        "graph_signals": {
          "support_weight": 0.5,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "不良反应的抵消效应",
              "pro": [
                "n_fish_oil_supplements"
              ],
              "con": [
                "n_rp"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "降低甘油三酯的补充剂"
          ],
          "safety_risk": [
            "不良反应可能抵消治疗收益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H12",
        "score": 0.34,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.4,
          "safety_risk": 0.25,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.15
        },
        "graph_signals": {
          "support_weight": 0.45,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "不良反应的抵消效应",
              "pro": [
                "n_red_yeast_rice"
              ],
              "con": [
                "n_rp"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "可能通过降低胆固醇影响甘油三酯"
          ],
          "safety_risk": [
            "不良反应可能抵消治疗收益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      }
    ],
    "ranking": [
      "H1",
      "H2",
      "H9",
      "H5",
      "H10",
      "H3",
      "H4",
      "H6",
      "H7",
      "H8",
      "H11",
      "H12"
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "n_fibrates",
          "type": "Drug",
          "label": "Fibrates",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_statins",
          "type": "Drug",
          "label": "Statins",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_omega_3_fatty_acids",
          "type": "Drug",
          "label": "Omega-3 fatty acids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_niacin",
          "type": "Drug",
          "label": "Niacin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_lipid_lowering_medications",
          "type": "Drug",
          "label": "Lipid-lowering medications",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ezetimibe",
          "type": "Drug",
          "label": "Ezetimibe",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_pcsk9_inhibitors",
          "type": "Drug",
          "label": "PCSK9 inhibitors",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_angiopoietin_like_3_inhibitors",
          "type": "Drug",
          "label": "Angiopoietin-like 3 inhibitors",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_gemfibrozil",
          "type": "Drug",
          "label": "Gemfibrozil",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_fenofibrate",
          "type": "Drug",
          "label": "Fenofibrate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_fish_oil_supplements",
          "type": "Drug",
          "label": "Fish oil supplements",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_red_yeast_rice",
          "type": "Drug",
          "label": "Red yeast rice",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_hypertriglyceridaemia",
          "type": "Disease",
          "label": "Severe hypertriglyceridaemia",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_omega_3",
          "type": "Drug",
          "label": "Omega-3 fatty acids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_lipid_lowering",
          "type": "Drug",
          "label": "Lipid-lowering medications",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_fish_oil",
          "type": "Drug",
          "label": "Fish oil supplements",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp",
          "type": "Pathway",
          "label": "Risk Pathway for Hypertriglyceridaemia",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv",
          "type": "Phenotype",
          "label": "Adverse Effects of Lipid-Lowering Therapies",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "edges": [
        {
          "source": "n_fibrates",
          "target": "n_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知对高甘油三酯血症的临床适应症"
        },
        {
          "source": "n_statins",
          "target": "n_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "具有降低甘油三酯的有效性"
        },
        {
          "source": "n_omega_3_fatty_acids",
          "target": "n_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "临床研究表明降低甘油三酯"
        },
        {
          "source": "n_niacin",
          "target": "n_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "对高甘油三酯血症有效的常识支持"
        },
        {
          "source": "n_lipid_lowering_medications",
          "target": "n_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "包含多种降脂药物的合成支持"
        },
        {
          "source": "n_ezetimibe",
          "target": "n_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "在治疗高脂血症中的作用"
        },
        {
          "source": "n_pcsk9_inhibitors",
          "target": "n_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "可能对高甘油三酯有辅助效果"
        },
        {
          "source": "n_angiopoietin_like_3_inhibitors",
          "target": "n_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "理论上对甘油三酯影响"
        },
        {
          "source": "n_gemfibrozil",
          "target": "n_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "用于高甘油三酯的已知药物"
        },
        {
          "source": "n_fenofibrate",
          "target": "n_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "有效降低甘油三酯的药物"
        },
        {
          "source": "n_fish_oil_supplements",
          "target": "n_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "降低甘油三酯的补充剂"
        },
        {
          "source": "n_red_yeast_rice",
          "target": "n_hypertriglyceridaemia",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "可能通过降低胆固醇影响甘油三酯"
        },
        {
          "source": "n_fibrates",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良反应"
        },
        {
          "source": "n_statins",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良反应"
        },
        {
          "source": "n_omega_3",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良反应"
        },
        {
          "source": "n_niacin",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良反应"
        },
        {
          "source": "n_lipid_lowering",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良反应"
        },
        {
          "source": "n_ezetimibe",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良反应"
        },
        {
          "source": "n_pcsk9_inhibitors",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良反应"
        },
        {
          "source": "n_angiopoietin_like_3_inhibitors",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良反应"
        },
        {
          "source": "n_gemfibrozil",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良反应"
        },
        {
          "source": "n_fenofibrate",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良反应"
        },
        {
          "source": "n_fish_oil",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良反应"
        },
        {
          "source": "n_red_yeast_rice",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良反应"
        },
        {
          "source": "n_rp",
          "target": "n_adv",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致不良表型"
        },
        {
          "source": "n_adv",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "不良反应可能抵消治疗收益"
        },
        {
          "source": "n_adv",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "不良反应可能抵消治疗收益"
        },
        {
          "source": "n_adv",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "不良反应可能抵消治疗收益"
        },
        {
          "source": "n_adv",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "不良反应可能抵消治疗收益"
        },
        {
          "source": "n_adv",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "不良反应可能抵消治疗收益"
        },
        {
          "source": "n_adv",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "不良反应可能抵消治疗收益"
        },
        {
          "source": "n_adv",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "不良反应可能抵消治疗收益"
        },
        {
          "source": "n_adv",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "不良反应可能抵消治疗收益"
        },
        {
          "source": "n_adv",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "不良反应可能抵消治疗收益"
        },
        {
          "source": "n_adv",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "不良反应可能抵消治疗收益"
        },
        {
          "source": "n_adv",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "不良反应可能抵消治疗收益"
        },
        {
          "source": "n_adv",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "不良反应可能抵消治疗收益"
        }
      ],
      "round_index": 4
    },
    "history": {
      "round": 4
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_fibrates",
          "name": "Fibrates"
        },
        "score": 0.48,
        "graph_snapshot_ref": "GE_H1_round4",
        "key_assumptions": [
          "Fibrates 有效对抗高甘油三酯血症",
          "存在潜在不良反应但总体疗效可接受"
        ],
        "caveats": [
          "不良反应可能抵消治疗收益"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_statins",
          "name": "Statins"
        },
        "score": 0.48,
        "graph_snapshot_ref": "GE_H2_round4",
        "key_assumptions": [
          "Statins 有效降低甘油三酯",
          "存在潜在不良反应但总体疗效可接受"
        ],
        "caveats": [
          "不良反应可能抵消治疗收益"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H9",
        "candidate": {
          "id": "drug_gemfibrozil",
          "name": "Gemfibrozil"
        },
        "score": 0.48,
        "graph_snapshot_ref": "GE_H9_round4",
        "key_assumptions": [
          "Gemfibrozil 是已知用于高甘油三酯的药物",
          "存在潜在不良反应但总体疗效可接受"
        ],
        "caveats": [
          "不良反应可能抵消治疗收益"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Fibrates / Statins / Gemfibrozil → Severe hypertriglyceridaemia",
          "reason": "这些药物在临床上已确立疗效，但存在可能的相同不良反应"
        }
      ],
      "remaining_gaps": [
        "需补充不良反应对各候选药物的具体影响与机制"
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [
            "seed_a",
            "seed_b"
          ],
          "impact_summary": "初步建立了对于高甘油三酯血症的基础药物候选地位"
        },
        {
          "round": 2,
          "seeds": [
            "seed_c",
            "seed_d"
          ],
          "impact_summary": "深入探索了不同药物机制与负面效应"
        },
        {
          "round": 3,
          "seeds": [
            "seed_e",
            "seed_f"
          ],
          "impact_summary": "在相同药物类中的比较，引发了对不良反应的关注"
        }
      ],
      "lessons": [
        "确认临床应用同时需关注不良反应的管理",
        "对疗效相似药物，需研究其不良反应的相对影响"
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "强调疗效的同时要识别潜在不良反应以避免抵消效果"
      },
      {
        "role": "Skeptic",
        "patch": "探讨相似疗效药物间不良反应的可能相互作用与影响"
      },
      {
        "role": "Explorer",
        "patch": "优先生成对于高甘油三酯且不良反应影响最小的新候选"
      }
    ],
    "heuristics": [
      {
        "when": "高甘油三酯治疗",
        "then": "识别各药物可能造成的共性不良反应，优先选择负面效应较低的选项"
      }
    ]
  }
}